Abnormal hemispheric blood flow and mtabolism in cerebrovascular disease. II. Therapeutic trials with 5 per cent CO 2  inhalation, hyperventilation and intravenous infusion of THAM and mannitol.
D000328:Adult; D000368:Aged; D001784:Blood Gas Analysis; D001794:Blood Pressure; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy; D002245:Carbon Dioxide / Q000378:metabolism / Q000627:therapeutic use*; D002496:Central Venous Pressure; D002533:Cerebral Angiography; D002540:Cerebral Cortex / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000378:metabolism / Q000628:therapy*; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007427:Intracranial Pressure / Q000187:drug effects; D002546:Ischemic Attack, Transient / Q000378:metabolism; D008297:Male; D008353:Mannitol / Q000627:therapeutic use*; D008875:Middle Aged; D010101:Oxygen Consumption; D012039:Regional Blood Flow / Q000187:drug effects; D012121:Respiration, Artificial; D014325:Tromethamine / Q000627:therapeutic use*
D014325:Tromethamine; D002245:Carbon Dioxide; D008353:Mannitol; D005947:Glucose